The silent mutation nucleotide 744 G → A, Lys172Lys, in exon 6 of BRCA2 results in exon skipping

Breast Cancer Research and Treatment

Volumn 119, Issue 3, 2010, Pages 547-550

  Hansen, Thomas V O ^a   Steffensen, Ane Y ^a   Jønson, Lars ^a   Andersen, Mette K ^a   Ejlertsen, Bent ^a   Nielsen, Finn C ^a  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

BRCA2; Breast cancer; Exon trapping; RT PCR; Silent mutation; Splicing

Indexed keywords

BRCA2 PROTEIN; RNA;

ADULT; ANIMAL CELL; ARTICLE; BREAST CANCER; CASE REPORT; EXON; FEMALE; HUMAN; ISOLATION PROCEDURE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EXONS; FEMALE; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; PEDIGREE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 74849119216     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0359-4     Document Type: Article

References (14)

1. A Antoniou PD Pharoah S Narod HA Risch JE Eyfjord JL Hopper N Loman H Olsson O Johannsson A Borg, et al. 2003 Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 5 1117 1130 10.1086/375033 10.1086/375033 1:CAS:528:DC%2BD3sXjslagtbg%3D 12677558 (Pubitemid 36530000)
2. K Gudmundsdottir A Ashworth 2006 The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability Oncogene 25 43 5864 5874 10.1038/sj.onc.1209874 10.1038/sj.onc.1209874 1:CAS:528:DC%2BD28XhtVSgurjM 16998501 (Pubitemid 44453442)
3. Hansen TVO, Jonson L, Albrechtsen A, Andersen MK, Ejlertsen B, Nielsen FC (2008) Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families. Breast Cancer Res Treat 12. doi: 10.1007/s10549-008-0088-0
4. M Thomassen TV Hansen A Borg HT Lianee F Wikman IS Pedersen ML Bisgaard FC Nielsen TA Kruse AM Gerdes 2008 BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer Acta Oncol 47 4 772 777 10.1080/02841860802004974 10.1080/02841860802004974 1:CAS:528: DC%2BD1cXnsFeitbg%3D 18465347 (Pubitemid 351878455)
5. Hansen TVO, Ejlertsen B, Albrechtsen A, Bergsten E, Bjerregaard P, Hansen T, Myrhoj T, Nielsen PB, Timmermans-Wielenga V, Andersen MK, et al (2008) A common Greenlandic Inuit BRCA1 RING domain founder mutation. Breast Cancer Res Treat 26. doi: 10.1007/s10549-008-0060-z
6. TV Hansen ML Bisgaard L Jonson A Albrechtsen B Filtenborg-Barnkob H Eiberg B Ejlertsen FC Nielsen 2008 Novel de novo BRCA2 mutation in a patient with a family history of breast cancer BMC Med Genet 9 58 10.1186/1471-2350-9-58 10.1186/1471-2350-9-58 18597679
7. MP Vreeswijk JN Kraan HM van der Klift GR Vink CJ Cornelisse JT Wijnen E Bakker CJ van Asperen P Devilee 2009 Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice-site prediction programs Hum Mutat 30 1 107 114 10.1002/humu.20811 10.1002/humu.20811 1:CAS:528:DC%2BD1MXivFygsbc%3D 18693280
8. DM Church CJ Stotler JL Rutter JR Murrell JA Trofatter AJ Buckler 1994 Isolation of genes from complex sources of mammalian genomic DNA using exon amplification Nat Genet 6 1 98 105 10.1038/ng0194-98 10.1038/ng0194-98 1:CAS:528:DyaK2cXhsFGis7o%3D 8136842 (Pubitemid 24191920)
9. Z Wang CB Burge 2008 Splicing regulation: from a parts list of regulatory elements to an integrated splicing code RNA 14 5 802 813 10.1261/rna.876308 10.1261/rna.876308 1:CAS:528:DC%2BD1cXls1Wrsbc%3D 18369186 (Pubitemid 351574901)
10. L Cartegni SL Chew AR Krainer 2002 Listening to silence and understanding nonsense: exonic mutations that affect splicing Nat Rev Genet 3 4 285 298 10.1038/nrg775 10.1038/nrg775 1:CAS:528:DC%2BD38XjtFOrtrc%3D 11967553 (Pubitemid 34279797)
11. P Maillet PO Chappuis M Khoshbeen-Boudal V Sciretta AP Sappino 2006 Twenty-three novel BRCA1 and BRCA2 sequence variations identified in a cohort of Swiss breast and ovarian cancer families Cancer Genet Cytogenet 169 1 62 68 10.1016/j.cancergencyto.2006.03.010 10.1016/j.cancergencyto.2006.03.010 1:CAS:528:DC%2BD28XntlCktbc%3D 16875939 (Pubitemid 44093731)
12. K Claes B Poppe E Machackova I Coene L Foretova A De Paepe L Messiaen 2003 Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2 Genes Chromosomes Cancer 37 3 314 320 10.1002/gcc.10221 10.1002/gcc.10221 1:CAS:528:DC%2BD3sXltFGgsbo%3D 12759930 (Pubitemid 36667570)
13. L Perrin-Vidoz OM Sinilnikova D Stoppa-Lyonnet GM Lenoir S Mazoyer 2002 The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons Hum Mol Genet 11 23 2805 2814 10.1093/hmg/11.23.2805 10.1093/hmg/11.23.2805 1:CAS:528:DC%2BD38XptFKntrk%3D 12393792
14. MD Ware D DeSilva OM Sinilnikova D Stoppa-Lyonnet SV Tavtigian S Mazoyer 2006 Does nonsense-mediated mRNA decay explain the ovarian cancer cluster region of the BRCA2 gene? Oncogene 25 2 323 328 1:CAS:528:DC%2BD28XjtV2isg%3D%3D 16170354